 Antagonism serotonin receptors ondansetron prevents nausea emesis cyclophosphamide-containing chemotherapy control nausea emesis cancer patients chemotherapy significant management problem randomized double-blind placebo-controlled study effect serotonin receptor blockade ondansetron GR prevention nausea vomiting cyclophosphamide-containing chemotherapy Cyclophosphamide doses ondansetron intravenous IV mg/kg patients cancer Cyclophosphamide combination doxorubicin patients fluorouracil patients Adriamycin doxorubicin Adria Columbus OH methotrexate placebo-treated patients patients ondansetron vomit Median nausea scores mm ondansetron mm placebo Seventy percent patients ondansetron normal appetite placebo patients Adverse events placebo patients ondansetron patient Diarrhea headache common events placebo group extrapyramidal reactions significant biochemical change placebo-treated patient results serotonin receptor antagonists novel effective safe mode therapy nausea emesis cyclophosphamide-containing chemotherapies addition observations compatible view serotonin receptors nausea emesis occurring cyclophosphamide chemotherapy